Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo
Clinical trial NCT01940848 · COMPLETED
Trial details
- NCT number
- NCT01940848
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-11
- Primary completion
- 2017-10-25
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.